ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
200806-100MG |
|
NA |
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide ≥95%,99%e.e. |
100MG | C60H85F3NO11PS | |
200758-100MG |
|
NA |
1,1,1-Trifluoro-N-(3aR,8aR)-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide ≥95%,99%e.e. |
100MG | C60H85F3NO11PS | |
200805-100MG |
|
NA |
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide ≥95%,99%e.e. |
100MG | C48H61F3NO7PS | |
200757-100MG |
|
NA |
1,1,1-Trifluoro-N-(3aR,8aR)-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide ≥95%,99%e.e. |
100MG | C48H61F3NO7PS | |
200804-100MG |
|
NA |
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetra-2-naphthalenyl-6-tetrahydro-6-hydroxy-2,2-dimethyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)methanesulfonamide ≥95%,99%e.e. |
100MG | C48H37F3NO7PS | |
200756-100MG |
|
NA |
1,1,1-Trifluoro-N-(3aR,8aR)-4,4,8,8-tetra-2-naphthalenyl-6-tetrahydro-6-hydroxy-2,2-dimethyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)methanesulfonamide ≥95%,99%e.e. |
100MG | C48H37F3NO7PS | |
200803-100MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetra-9-phenanthrenel-tetrahydro-6-hydroxy-2,2-dimethyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin ≥95%,99%e.e. |
100MG | C63H45O6P | |
200779-100MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetra-9-phenanthrenel-tetrahydro-6-hydroxy-2,2-dimethyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin ≥95%,99%e.e. |
100MG | C63H45O6P | |
200802-250MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-o-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
250MG | C75H101O6P | |
200802-100MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-o-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
100MG | C75H101O6P | |
200778-250MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-o-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
250MG | C75H101O6P | |
200778-100MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-o-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
100MG | C75H101O6P | |
200801-250MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-m-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
250MG | C75H101O6P | |
200801-100MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-m-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
100MG | C75H101O6P | |
200777-250MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-m-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
250MG | C75H101O6P | |
200777-100MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-m-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
100MG | C75H101O6P | |
200800-250MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
250MG | C75H101O6P | |
200800-100MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
100MG | C75H101O6P | |
200776-250MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
250MG | C75H101O6P | |
200776-100MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
100MG | C75H101O6P | |